Update this profile
Cephalon General Information Description
Cephalon was a provider and developer of medicines for central nervous system disorders, pain and cancer. The company's research, development, manufacturing, and marketing activities focused on therapies for central nervous system disorders, cancer, pain and inflammatory disease. It offered its products through distributors in the United States and internationally. The company was founded in 1987 and was headquartered in Frazer, Pennsylvania.
Want to dig into this profile?
We’ll help you find what you need
Cephalon Valuation & Funding
Raised to Date
1. Early Stage VC
To view Cephalon’s complete valuation and funding history, request access »
0.80%, 93rd %ile
219x, 100th %ile
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
Investments & Acquisitions (20)
0000000000 0ü0 000 10-Jan-2012
00000 0 0000000000 01-Apr-2011
000000000 00000000 29-Mar-2011
Alba Therapeutics (Larazotide Acetate Assets)
Corporate Asset Purchase
0000 Buildings and Property
You’re viewing 5 of 20 investments and acquisitions. Get the full list »